SAMSUNG BIOLOGICS CO.,LTD. Logo

SAMSUNG BIOLOGICS CO.,LTD.

A contract development and manufacturing organization for the biopharmaceutical industry.

207940 | KO

Overview

Corporate Details

ISIN(s):
KR7207940008
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도바이오대로 300, 인천광역시

Description

Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that provides end-to-end services to the biopharmaceutical industry. The company offers a comprehensive suite of solutions covering the entire product lifecycle, from early-stage cell line and process development to large-scale commercial manufacturing of drug substances. Key services include analytical development, quality and biosafety testing, and aseptic fill/finish of drug products. Samsung Biologics also supports the development and manufacturing of new modalities, including antibody-drug conjugates (ADCs) and mRNA. Leveraging its large-scale, CGMP-compliant facilities, the company serves a global client base of pharmaceutical companies with tailored and flexible manufacturing solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-07-10 00:00
결산실적공시예고(안내공시)
Korean 4.6 KB
2024-07-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.8 KB
2024-07-02 00:00
단일판매ㆍ공급계약체결
Korean 8.9 KB
2024-07-02 00:00
[기재정정]투자판단관련주요경영사항
Korean 12.3 KB
2024-06-28 00:00
기타시장안내 (업종변경)
Korean 5.8 KB
2024-06-26 00:00
[기재정정]투자판단관련주요경영사항
Korean 14.2 KB
2024-06-26 00:00
[기재정정]투자판단관련주요경영사항
Korean 16.0 KB
2024-06-25 00:00
[기재정정]투자판단관련주요경영사항
Korean 11.9 KB
2024-06-25 00:00
단일판매ㆍ공급계약체결
Korean 8.5 KB
2024-06-25 00:00
[기재정정]투자판단관련주요경영사항
Korean 11.8 KB
2024-06-24 00:00
최대주주등소유주식변동신고서
Korean 41.1 KB
2024-06-18 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 17.1 KB
2024-05-31 00:00
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 191.2 KB
2024-05-31 00:00
[기재정정]투자판단관련주요경영사항
Korean 11.5 KB
2024-05-30 00:00
지속가능경영보고서등관련사항(자율공시)
Korean 17.7 KB

Automate Your Workflow. Get a real-time feed of all SAMSUNG BIOLOGICS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMSUNG BIOLOGICS CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMSUNG BIOLOGICS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.